School of Medicine
Showing 101-150 of 178 Results
-
Stavros Melemenidis
Director of Pre-clinical Radiotherapy, Radiation Oncology - Radiation Therapy
Current Role at StanfordCurrently, I serve as the Deputy Director of the Pre-clinical Radiotherapy core of the Radiation Oncology department, where I lead a team of Physics Assistants focused on developing dosimetric consensus across pre-clinical orthovoltage and MeV irradiation platforms. We implement clinical calibration and quality assurance principles in preclinical settings. The core provides equipment training to users, offers treatment planning support, and provides services for custom 3D-design, fabrication, and characterization of collimators and shielding for in vivo radiation treatments.
Concurrently, I have been a research scientist at the Loo laboratory. Our laboratory stands at the forefront of FLASH radiobiology research, providing the only pre-clinical FLASH electron platforms to over 10 laboratories spanning various disciplines, while our multi-institutional and international collaborations focus on introducing dosimetric harmonization across various FLASH electron platforms. -
Lynn Million
Clinical Professor, Radiation Oncology - Radiation Therapy
BioLynn Million specializes in the treatment of cancer. She has practiced Radiation Oncology for more than 30 years. Dr. Million has a special interest in the treatment of sarcoma’s of soft tissue, bone and cartilage in children, young adolescents and adults.
-
Seyed Hossein Mirjahanmardi
Postdoctoral Scholar, Radiation Physics
BioSeyed Hossein Mirjahanmardi currently serves as a postdoctoral fellow in Medical Physics at Stanford University. He earned his Ph.D. with honors in electrical and computer engineering from the University of Waterloo, Canada, in 2020. Dr. Mirjahanmardi is a senior member of IEEE and has been honored with the Natural Sciences and Engineering Research Council of Canada (NSERC) fellowship award. His expertise and industry experience extend from Electromagnetics and RF design to Computational Pathology and High-dimensional Data Analysis, primarily focusing on Artificial Intelligence (AI) algorithms. His focus is inventing technologies in AI, computational pathology, and Electromagnetics for healthcare applications. His PhD research and current works at Stanford have been highlighted widely in the news.
-
Everett J. Moding, MD, PhD
Assistant Professor of Radiation Oncology (Radiation Therapy)
Current Research and Scholarly InterestsMy laboratory performs translational research using analysis of human samples to identify critical mediators of treatment resistance that can be validated in preclinical models and targeted to enhance the efficacy of cancer therapy.
-
Prithvi Mruthyunjaya, MD, MHS
Professor of Ophthalmology and, by courtesy, of Radiation Oncology
Current Research and Scholarly InterestsDr Mruthyunjaya has maintained a broad research interest with publications in both ocular oncology and retinal diseases.
His focus is on multi-modal imaging of ocular tumors and understanding imaging clues that may predict vision loss after ocular radiation therapy. He coordinates multi-center research on the role of genetic testing and outcomes of treatments of ocular melanoma.
In the field of retinal diseases, his interests are in intra-operative imaging to enhance surgical accuracy. -
Rohollah Nasiri
Postdoctoral Scholar, Radiation Physics
Current Research and Scholarly InterestsMy research focuses on advancing cancer treatment through the integration of tumor-on-a-chip models with radiation therapy
-
Jinghong Penny Peng
Clinical Instructor, Radiation Oncology - Radiation Physics
Current Research and Scholarly Interests1. IMRT Treatment planning
2. IGRT Radiation Therapy
3. Real time prostate implant
4. 4D CT and Respiratory Gating Radiation Therapy
5. HDR for breast cancer and GYN cancer
6. Xoft Electronic Brachytherapy -
Guillem Pratx
Associate Professor of Radiation Oncology (Radiation Physics)
Current Research and Scholarly InterestsThe Physical Oncology Lab is interested in making a lasting impact on translational cancer research by building novel physical tools and methods.
-
Yushen Qian, MD
Clinical Assistant Professor, Radiation Oncology - Radiation Therapy
BioDr. Qian is a board-certified radiation oncologist and a clinical assistant professor in the Stanford University School of Medicine, Department of Radiation Oncology.
In his clinical practice, he specializes in urologic, head and neck, and thoracic cancers, but treats a broad spectrum of cancers including lymphoma, gastrointestinal, and brain tumors. For each patient, he develops a comprehensive, compassionate care plan customized to individual needs. His goal is to deliver the most effective cancer treatment to help patients enjoy the best possible health and quality of life.
In addition to his clinical practice, Dr. Qian has conducted extensive research that is often focused on the impact of radiation therapy on patient outcomes and health care system costs.
He has presented the findings at annual meetings of the American Radium Society, American Society for Radiation Oncology, American Society of Clinical Oncology Cancer Survivorship Symposium, Palliative Care in Oncology Symposium, and elsewhere.
Dr. Qian has published articles in journals such as Clinical Cancer Research, the Journal of Clinical Oncology, Practical Radiation Oncology, the International Journal of Radiation Oncology • Biology • Physics (IJROBP), and more.
Dr. Qian co-authored the chapter on radiation therapy for liver tumors in the book Radiation Therapy for Hepatocellular Carcinoma: Clinical Data. He also co-authored the chapter on liver care for the book Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy.
He has earned numerous honors, including the Malcolm A. Bagshaw Award for leadership and outstanding scientific achievement. -
Chenhui Qiu
Postdoctoral Scholar, Radiation Physics
BioChenhui Qiu majored in Biomedical Engineering and received Ph.D at Zhejiang University.
Then, was a postdoc and research assistant (medium-grade professional title) at Department of Applied Mathematics, School of Mathematical Sciences, Zhejiang University.
Currently, is a postdoc at Department of Radiation Oncology, School of Medicine, Stanford University.
His research interests are medical image registration & fusion, radiation-based neuromodulation & neuro-oncology, dose calculation & treatment planning, wavelet & sparse representation, intelligent computing, convex optimization, AI machine learning. -
Elham Rahimy, MD
Clinical Assistant Professor, Radiation Oncology - Radiation Therapy
BioDr. Rahimy is a radiation oncologist who treats patients with brain, spine, and gastrointestinal tumors. She received her medical training at Yale, followed by a residency in radiation oncology at Stanford. She is a clinical assistant professor with the Stanford School of Medicine Department of Radiation Oncology.
Dr. Rahimy specializes in treating several types of cancer, including brain tumors, such as glioma and glioblastoma, spine tumors, metastatic disease, and gastrointestinal cancer, such as rectal cancer and pancreatic cancer. She is credentialed for CyberKnife Radiosurgery. She is also actively involved in radiation oncology research and clinical trials. Her interests include improving patient and resident education and enhancing patient quality of life and survivorship. Dr. Rahimy’s research has been published in a variety of journals. She is also the current radiation oncology medical student clerkship director. -
Mohammad Shahrokh Esfahani
Assistant Professor of Radiation Oncology (Radiation and Cancer Biology)
BioWith a primary focus on high-dimensional data, I have significant expertise in developing machine learning tools. Much of my work involves constructing Bayesian models, which effectively convert 'prior knowledge', either inherent in the dataset or obtained from external sources, into mathematical terms—more specifically, prior probabilities.
My recent research efforts have centered on the analysis of genetic and epigenetic signals within cell-free DNA assays. This interest in epigenetics led to the development of a pioneering technique known as EPIC-seq, which has broadened our understanding of this complex field.
It's notable that traditional computational methods in cancer genomics often fall short when confronted with an exceedingly low signal-to-noise ratio—a common scenario in cfDNA analyses. As such, there's an emerging need to devise innovative, robust methods capable of overcoming this limitation—a research area that I'm deeply committed to and actively engaged in. -
Lawrie Skinner
Clinical Assistant Professor, Radiation Oncology - Radiation Physics
BioDr Skinner is a Board certified therapeutic medical physicist with interests in novel 3D printed devices and a research background in synchrotron x-ray scattering, neutron scattering, molecular dynamics and Monte Carlo computational modelling.
-
Kendric C. Smith
Professor of Radiation Oncology, Emeritus
Current Research and Scholarly InterestsThe photochemistry and radiation chemistry of DNA, the genetic control and biochemical bases of the multiple pathways of DNA repair, and the roles of DNA repair processes in radiation and spontaneous mutagenesis. Over 190 papers have been published on these and related topics.
-
Scott G. Soltys, MD
Professor of Radiation Oncology (Radiation Therapy) and, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsMy clinical and research interests focus on the development of new radiation techniques involving stereotactic radiosurgery and radiotherapy for the treatment of malignant and benign tumors of the brain and spine, as well as functional disorders such as trigeminal neuralgia.
-
Liyan Sun
Postdoctoral Scholar, Radiation Physics
Current Research and Scholarly InterestsPhysics-driven deep learning algorithms for MRI/CT reconstruction and analysis:
(1) MRI acceleration with partial measurements.
(2) Medical image segmentation under limited data resources.
(3) Unsupervised/supervised medical image synthesis for MRI or CT.
(4) Longitudinal medical data analysis with deep learning models.
(5) PET image reconstruction and analysis. -
Gregory Arthur Szalkowski
Clinical Assistant Professor, Radiation Oncology - Radiation Physics
Current Research and Scholarly InterestsWorkflow automation, radiotherapy quality assurance, machine learning
-
Kekoa Taparra, MD, PhD
Resident in Radiation Oncology - Radiation Therapy
BioAloha, my name is Kekoa and I am an Indigenous Native Hawaiian born and raised in Mililani, Oʻahu, Hawaiʻi. My life's mission is to return home to the islands and provide high-quality cancer care to the communities that raised me. I earned my PhD from Johns Hopkins School of Medicine (Cellular and Molecular Medicine) and my MD from Mayo Clinic Alix School of Medicine (Science of Healthcare Delivery Certification), experiences that have prepared me for my current role as a resident physician and postdoctoral medical fellow in the Department of Radiation Oncology at Stanford Health Care. I am a Masters of Public Health Merit Award scholar at Hawaiʻi Pacific University. I'm proud to be a member of the inaugural cohort of the President Barack Obama Foundation Leaders USA program. I also run a lab with over 20 talented Native Hawaiian and other Pacific Islander (NHPI) and NHPI-ally scholars across the nation, focusing on unmasking NHPI health disparities that have been overlooked for decades.
My lab specifically focuses on Pacific Islander health disparities, overcoming Indigenous Erasure, resolving structural racism in NHPI data, and sustainable climate-resilient healthcare systems. We use perspectives from the lived experiences of our communities to help guide the most pertinent research questions. For my research, I have been awarded the inaugural 2023 ASCO Dr. Judith and Alan Kaur Endowed Young Investigator Award along with awards from ASH, ASTRO, NMF, and AACR. My work has been published in The Lancet, NEJM, JAMA, JAMA Oncology, JAMA Internal Medicine, JAMA Health Forum, JNCI, and JCO Oncology Practice, among others. I was selected as a 2022-2023 American Society of Clinical Oncology Journals Editorial Fellow and a 2023-2024 Stanford Cancer Institute Fellow.
As an advocate for Pacific Islander health equity, I strive to engage with community partners, federal agencies, and academic research institutions to educate others on the unique health concerns of our population. I've been invited to speak on NHPI health at institutions such as Harvard, MDACC Grand Rounds, UCLA, UCSF, NIH/NCI, FDA, and Papa Ola Lōkahi, among others. I warmly welcome interdisciplinary collaborations that aim to improve the health of our underserved Pacific Islander communities. -
Nicholas Trakul, MD, PhD
Clinical Associate Professor, Radiation Oncology - Radiation Therapy
BioDr. Nicholas Trakul is a radiation oncologist with Stanford Medicine Cancer Center and clinical associate professor of Radiation Oncology-Radiation Therapy with Stanford School of Medicine. Dr. Trakul serves as Medical Director for Stanford Medicine Radiation Oncology in Pleasanton and for the Stanford Medicine I Sutter Health Cancer Collaborative in Castro Valley.
Dr. Trakul completed residency training at Stanford in 2013 and then joined the faculty at the University of Southern California, where he specialized in head and neck and central nervous system malignancies, with an emphasis on stereotactic radiosurgery (SRS) and stereotactic ablative radiotherapy (SABR/SBRT). He is widely published as first author in peer-reviewed journals. His research focus involves the creation of novel clinical databases as well as outcomes in the treatment of head and neck, gastrointestinal and thoracic malignancies. In 2017, Dr. Trakul returned to Stanford Medicine, becoming the Medical Director of Stanford Medicine Radiation Oncology in Pleasanton. In 2020, he was named Medical Director of Stanford Radiation Oncology Network Sites. In February 2022, Dr. Trakul assumed the medical directorship of Eden Radiation Oncology Center, the first site to become operation under the Stanford/Sutter Cancer Collaborative. He is focused on providing access to high quality radiation therapy, collaboration with community health care systems and creating/maintaining productive and high engagement workplace culture. He believes in providing personalized, high-quality care, and bringing new technology to the East Bay, allowing patients to access cancer care while staying connected to their communities and support networks.
